Skip to main content

Series B Biopharma Companies

Explore 97 biopharma startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
97
Total Funding
$2.2B
Avg Funding
$87.3M
Cities
20

Export 97 Series B Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boston, United States
$135.0M
raised

Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.

Oct 2026
Series B

Founder Contacts

41,000+ verified contacts

$955K
raised

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Oct 2026
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$80.0M
raised

KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.

Oct 2026
Series B

Founder Contacts

41,000+ verified contacts

Solna, Sweden
$70.8M
raised

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Sep 2026
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$70.0M
raised

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Sep 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$50.0M
raised

Khartis is a drug discovery company developing oral therapies for immune-mediated and chronic diseases, with a focus on treatments and care.

Aug 2026
Series B

Founder Contacts

41,000+ verified contacts

Jersey City, United States
$118.0M
raised

Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$130.0M
raised

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom
$65.0M
raised

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$62.0M
raised

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Austin, United States
$330.0M
raised

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$125.0M
raised

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$99.5M
raised

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

$38.0M
raised

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

Boulder, United States
$100.0M
raised

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Mar 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Doylestown, United States
$89.0M
raised

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Mar 2026
Series B

Founder Contacts

41,000+ verified contacts

Budapest, Hungary
$25.0M
raised

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

New York, United States
$2.2M
raised

Epikast provides technology-enabled commercial and clinical services for the biopharmaceutical industry.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$33.5M
raised

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$63.5M
raised

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Watertown, United States
$125.0M
raised

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$55.0M
raised

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$84.0M
raised

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Woburn, United States
$110.0M
raised

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Lexington, United States
$120.0M
raised

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 97 companies

Ready to Connect with Series B Biopharma Startups?

Get verified founder emails, funding details, and company data for 97 series b biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked